No headlines found.
Cohen & Steers Closed-End Funds Declare Distributions for October, November, and December 2026
PRNewswire (Tue, 22-Sep 5:02 PM ET)
Cohen & Steers Announces Preliminary Assets Under Management and Net Flows for August 2026
PRNewswire (Wed, 9-Sep 4:27 PM ET)
Cohen & Steers and Trademark Acquire Oak Hill Plaza Shopping Center in Austin, Texas
PRNewswire (Mon, 31-Aug 9:48 AM ET)
PRNewswire (Fri, 28-Aug 5:53 PM ET)
PRNewswire (Fri, 28-Aug 5:49 PM ET)
PRNewswire (Fri, 28-Aug 5:27 PM ET)
PRNewswire (Fri, 28-Aug 5:14 PM ET)
PRNewswire (Fri, 28-Aug 5:00 PM ET)
Cohen & Steers and DLC Acquire Royal Plaza Grocery Shopping Center in Front Royal, Virginia
PRNewswire (Mon, 17-Aug 11:00 AM ET)
Cohen & Steers Announces Changes to Realty Indexes
PRNewswire (Fri, 14-Aug 4:05 PM ET)
Cohen & Steers is a niche asset manager concentrating on real estate securities. The firm invests primarily in the equity shares of real estate investment trusts, with holdings in domestic and international real estate securities accounting for nearly two-thirds of its $102.5 billion in managed assets at the end of July 2026. Cohen & Steers also manages portfolios dedicated to preferred securities, utilities stocks, and other high-yield offerings. The firm's distribution is balanced among its closed-end funds, open-end funds, and institutional accounts. During the past four calendar quarters, the company garnered 39% (25%) of its managed assets (base management fees) from institutional clients, 48% (55%) from open-end funds, and 13% (20%) from closed-end funds.
Cohen & Steers trades on the NYSE stock market under the symbol CNS.
As of September 23, 2026, CNS stock price climbed to $75.53 with 249,219 million shares trading.
CNS has a beta of 0.49, meaning it tends to be less sensitive to market movements. CNS has a correlation of 0.05 to the broad based SPY ETF.
CNS has a market cap of $3.88 billion. This is considered a Mid Cap stock.
Last quarter Cohen & Steers reported $153 million in Revenue and $.85 earnings per share. This beat revenue expectation by $3 million and exceeded earnings estimates by $.02.
In the last 3 years, CNS traded as high as $110.67 and as low as $50.05.
The top ETF exchange traded funds that CNS belongs to (by Net Assets): VTI, SCHD, VB, VBK, VXF.
CNS has underperformed the market in the last year with a price return of +16.2% while the SPY ETF gained +16.3%. CNS has also underperformed the stock market ETF in the last 3 month and 2 week periods returning +0.8% and -3.4%, respectively, while the SPY returned +3.4% and +0.5%, respectively.
CNS support price is $72.91 and resistance is $76.17 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that CNS shares will trade within this expected range on the day.
